Identification and Evaluation of Biomarkers of Resistance to Neoadjuvant Chemotherapy (IDEA SEIN)
Biomarkers of resistance to neoadjuvant chemotherapy in locally advanced breast cancer
Breast Cancer
BIOLOGICAL: Blood sample
predictive molecular abnormalities assessment, Highlighting and study of predictive molecular abnormalities of resistance to neoadjuvant chemotherapy in locally advanced breast cancer, up to 5 years
Identification and evaluation of biomarkers of resistance to neoadjuvant chemotherapy and establishment of preclinical models of resistance in locally advanced breast cancer